×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Nautilus Biotechnology Inc. (NAUT) NASDAQ

$2.34 (0.09) (-3.70%)

Market Cap: $303.99M

As of 04/18/24 04:00 PM EDT. Market closed.

(NAUT)

Nautilus Biotechnology Inc. (NAUT)
NASDAQ

$2.34
(0.09) (-3.70%)

Market Cap: $303.99M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive ... read more

born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Full Time Employees
170
URL
Address
.
PRICE CHART FOR NAUTILUS BIOTECHNOLOGY INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.43
Previous Close
$2.43
Days Range
$2.33 - $2.51
52 week range
$2.16 - $4.65
Volume
99,733
Avg. Volume (30 days)
65,780
Market Cap
$303.99M
Dividend Yield
-
P/E
-
Shares Outstanding
125,098,080
Open
$2.43
Previous Close
$2.43
Days Range
$2.33 - $2.51
52 week range
$2.16 - $4.65
Volume
99,733
Avg. Volume (30 days)
65,780
Market Cap
$303.99M
Dividend Yield
-
P/E
-
Shares Outstanding
125,098,080
FINANCIAL STATEMENTS FOR NAUTILUS BIOTECHNOLOGY INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NAUTILUS BIOTECHNOLOGY INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Patel Sujal MCEO, President, and SecretaryMar 11, 2024 Buy$2.8412,04434,21610,064,488Mar 11, 2024, 08:21 PM
Patel Sujal MCEO, President, and SecretaryMar 08, 2024 Buy$2.992,4307,26210,052,444Mar 11, 2024, 08:21 PM
Patel Sujal MCEO, President, and SecretaryMar 07, 2024 Buy$2.8918,85454,42410,050,014Mar 07, 2024, 07:06 PM
Patel Sujal MCEO, President, and SecretaryMar 06, 2024 Buy$2.709,26725,03410,031,160Mar 07, 2024, 07:06 PM
Patel Sujal MCEO, President, and SecretaryMar 05, 2024 Buy$2.657,40519,59710,021,893Mar 07, 2024, 07:06 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 27, 2022 Buy$2.035,00010,14991,250Sep 28, 2022, 04:01 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 26, 2022 Buy$2.0310,00020,25086,250Sep 28, 2022, 04:01 PM
Weld Gwen EChief People OfficerSep 23, 2022 Buy$2.0330,00060,76530,000Sep 26, 2022, 09:26 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 16, 2022 Buy$2.1635,00075,44675,000Sep 19, 2022, 05:50 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 15, 2022 Buy$2.1940,00087,75240,000Sep 19, 2022, 05:50 PM
Mowry AnnaCFO and TreasurerAug 19, 2022 Buy$2.3017,50040,21856,750Aug 22, 2022, 07:40 PM
Murphy Matthew B.General CounselAug 12, 2022 Buy$2.852,5007,12546,640Aug 16, 2022, 08:19 PM
Murphy Matthew B.General CounselAug 15, 2022 Buy$2.847,50021,30854,140Aug 16, 2022, 08:19 PM
Patel Sujal MCEO, President, and SecretaryAug 08, 2022 Buy$2.938,34624,44410,014,488Aug 08, 2022, 07:48 PM
Patel Sujal MCEO, President, and SecretaryAug 05, 2022 Buy$2.9241,654121,64610,006,142Aug 08, 2022, 07:48 PM
Mowry AnnaCFO and TreasurerJun 27, 2022 Buy$2.755,50015,12439,250Jun 28, 2022, 06:17 PM
Murphy Matthew B.General CounselMay 12, 2022 Option Exercise$3.2810,00032,80044,140May 13, 2022, 05:09 PM
Patel Sujal MCEO, President, and SecretaryMay 09, 2022 Buy$3.9650,000198,0009,964,488May 10, 2022, 08:28 PM
Patel Sujal MCEO, President, and SecretaryMar 04, 2022 Option Exercise$10.001001,0009,914,488Mar 04, 2022, 05:39 PM
Patel Sujal MCEO, President, and SecretaryMar 03, 2022 Buy$3.6050,000179,8909,914,388Mar 04, 2022, 05:39 PM
PERCEPTIVE ADVISORS LLCDirectorDec 08, 2021 Buy$5.36200,0001,072,0009,111,151Dec 10, 2021, 04:05 PM
Patel Sujal MCEO, President, and SecretaryDec 01, 2021 Buy$4.7388,022416,3979,864,388Dec 02, 2021, 08:49 AM
Patel Sujal MCEO, President, and SecretaryNov 30, 2021 Buy$4.72161,978764,7799,776,366Dec 02, 2021, 08:49 AM
Posard Matthew L.DirectorDec 01, 2021 Buy$4.4730,000134,10550,000Dec 01, 2021, 09:41 PM
Posard Matthew L.DirectorNov 30, 2021 Buy$4.5720,00091,40020,000Dec 01, 2021, 09:41 PM
Mowry AnnaCFO and TreasurerNov 24, 2021 Buy$4.5815,00068,63332,500Nov 24, 2021, 05:12 PM
McIlwain Matthew SDirectorNov 15, 2021 Buy$5.30100,000529,890459,075Nov 17, 2021, 08:19 PM
McIlwain Matthew SDirectorAug 26, 2021 Buy$7.7111,70990,314359,075Aug 26, 2021, 07:29 PM
McIlwain Matthew SDirectorAug 25, 2021 Buy$7.7411,69390,458347,366Aug 26, 2021, 07:29 PM
McIlwain Matthew SDirectorAug 24, 2021 Buy$7.6813,568104,269335,673Aug 26, 2021, 07:29 PM
Mowry AnnaCFO and TreasurerAug 12, 2021 Buy$7.7117,500134,92517,500Aug 16, 2021, 05:12 PM
Murphy Matthew B.General CounselAug 13, 2021 Buy$7.565,00037,80634,140Aug 13, 2021, 09:01 PM
PERCEPTIVE ADVISORS LLCFormer DirectorJun 09, 2021 Buy$10.005,500,00055,000,0005,997,038Jun 11, 2021, 05:45 PM
PERCEPTIVE ADVISORS LLCFormer DirectorMay 24, 2021 Buy$10.057,06370,983497,038Jun 11, 2021, 05:45 PM
PERCEPTIVE ADVISORS LLCDirectorJun 03, 2021 Buy$10.05330,0503,317,003489,975Jun 03, 2021, 06:55 PM
PERCEPTIVE ADVISORS LLCDirectorMay 20, 2021 Buy$10.05159,9251,607,246159,925May 24, 2021, 06:49 PM
ARYA Sciences Holdings III10% OwnerAug 11, 2020 Option Exercise$10.00499,0004,990,000499,000Aug 11, 2020, 08:48 PM
Stone Adam LeoChief Executive OfficerAug 11, 2020 Option Exercise$10.00499,0004,990,000499,000Aug 11, 2020, 08:43 PM
ALTMAN MICHAEL SETHChief Financial OfficerAug 11, 2020 Option Exercise$10.00499,0004,990,000499,000Aug 11, 2020, 08:38 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Patel Sujal MCEO, President, and Secretary03/11/202434,216
Patel Sujal MCEO, President, and Secretary03/08/20247,262
Patel Sujal MCEO, President, and Secretary03/07/202454,424
Patel Sujal MCEO, President, and Secretary03/06/202425,034
Patel Sujal MCEO, President, and Secretary03/05/202419,597
Sankar SubramanianSenior VP, Product Development09/27/202210,149
Sankar SubramanianSenior VP, Product Development09/26/202220,250
Weld Gwen EChief People Officer09/23/202260,765
Sankar SubramanianSenior VP, Product Development09/16/202275,446
Sankar SubramanianSenior VP, Product Development09/15/202287,752
Mowry AnnaCFO and Treasurer08/19/202240,218
Murphy Matthew B.General Counsel08/12/20227,125
Murphy Matthew B.General Counsel08/15/202221,308
Patel Sujal MCEO, President, and Secretary08/08/202224,444
Patel Sujal MCEO, President, and Secretary08/05/2022121,646
Mowry AnnaCFO and Treasurer06/27/202215,124
Murphy Matthew B.General Counsel05/12/202232,800
Patel Sujal MCEO, President, and Secretary05/09/2022198,000
Patel Sujal MCEO, President, and Secretary03/04/20221,000
Patel Sujal MCEO, President, and Secretary03/03/2022179,890
PERCEPTIVE ADVISORS LLCDirector12/08/20211,072,000
Patel Sujal MCEO, President, and Secretary12/01/2021416,397
Patel Sujal MCEO, President, and Secretary11/30/2021764,779
Posard Matthew L.Director12/01/2021134,105
Posard Matthew L.Director11/30/202191,400
Mowry AnnaCFO and Treasurer11/24/202168,633
McIlwain Matthew SDirector11/15/2021529,890
McIlwain Matthew SDirector08/26/202190,314
McIlwain Matthew SDirector08/25/202190,458
McIlwain Matthew SDirector08/24/2021104,269
Mowry AnnaCFO and Treasurer08/12/2021134,925
Murphy Matthew B.General Counsel08/13/202137,806
PERCEPTIVE ADVISORS LLCFormer Director06/09/202155,000,000
PERCEPTIVE ADVISORS LLCFormer Director05/24/202170,983
PERCEPTIVE ADVISORS LLCDirector06/03/20213,317,003
PERCEPTIVE ADVISORS LLCDirector05/20/20211,607,246
ARYA Sciences Holdings III10% Owner08/11/20204,990,000
Stone Adam LeoChief Executive Officer08/11/20204,990,000
ALTMAN MICHAEL SETHChief Financial Officer08/11/20204,990,000
Load More Insider Transactions
FUNDS WITH A POSITION IN NAUTILUS BIOTECHNOLOGY INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,893,6370.0003%4.14%Other
GEODE CAPITAL MANAGEMENT, LLC1,065,2540.00033%5%Other
RENAISSANCE TECHNOLOGIES LLC116,7000.00054%-0.09%Other
CHANGE IN SHARES OUTSTANDING FOR NAUTILUS BIOTECHNOLOGY INC
STOCK BUYBACKS FOR NAUTILUS BIOTECHNOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.04%
1Q
12/31/2023
06/30/2023
0.31%
2Q
12/31/2023
03/31/2023
0.32%
3Q
12/31/2023
12/31/2022
0.16%
4Q
12/31/2023
09/30/2022
0.27%
5Q
12/31/2023
06/30/2022
0.39%
6Q
12/31/2023
03/31/2022
0.46%
7Q
12/31/2023
12/31/2021
47.97%
8Q
12/31/2023
09/30/2021
0.70%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.04%
1Q
06/30/2023
0.31%
2Q
03/31/2023
0.32%
3Q
12/31/2022
0.16%
4Q
09/30/2022
0.27%
5Q
06/30/2022
0.39%
6Q
03/31/2022
0.46%
7Q
12/31/2021
47.97%
8Q
09/30/2021
0.70%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NAUTILUS BIOTECHNOLOGY INC
LOADING...